Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mateo

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Thrombosis Research|June 13, 2022
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII productsJ E Megías-Vericat, S Bonanad Boix, R Berrueco Moreno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2020
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancerM P Kolinsky, P Rescigno, D Bianchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practiceC B Westphalen, L Boscolo Bielo, P Aftimos, et al.
ESMO Open|September 2, 2023
Young oncologists' perspective on the role and future of the clinician-scientist in oncologyK H J Lim, C B Westphalen, A S Berghoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)M Aldea, M Salto-Tellez, A Marra, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Thrombosis Research|June 13, 2022
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII productsJ E Megías-Vericat, S Bonanad Boix, R Berrueco Moreno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2020
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancerM P Kolinsky, P Rescigno, D Bianchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practiceC B Westphalen, L Boscolo Bielo, P Aftimos, et al.
ESMO Open|September 2, 2023
Young oncologists' perspective on the role and future of the clinician-scientist in oncologyK H J Lim, C B Westphalen, A S Berghoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)M Aldea, M Salto-Tellez, A Marra, et al.
Pageof 25